$AI

Lath Hitesh sold $426K of AI

Lath Hitesh (CHIEF FINANCIAL OFFICER) sold 48,619 shares of C3.ai, Inc. (AI) at $8.77 ($0.43M total) across 2 trades on 2026-06-30 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Lath Hitesh
Published Jul 1, 2026, 10:43 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 10:44 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AI
Neutral
medium confidence
Mentioned
$AI
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AINeutralLow
01

Why it matters

This adds a concrete datapoint on insider selling activity, but the presence of a pre-arranged 10b5-1 plan generally lowers the likelihood of a strong negative fundamental inference.

02

Market read

Traders may briefly reassess sentiment around insider selling, but there is no new operational or financial catalyst in the text.

03

What to watch

The disclosure does not indicate whether other insiders or the company’s fundamentals changed; without accompanying guidance/earnings, the trading signal is mostly sentiment-based.

Relevance 3/10Novelty 5/10Timing: after-hours/filing day (Form 4 filed 2026-07-01)

Background

The article is a SEC Form 4 insider transaction: CFO Lath Hitesh sold shares on 2026-06-30 and the filing was submitted on 2026-07-01.

Company-level read

Ticker impact

$AINeutralMedium confidence
Context

C3.ai CFO Lath Hitesh filed a Form 4 selling 48,619 shares at $8.77 on 2026-06-30 under a 10b5-1 plan.

Expected impact

Near-term impact likely muted; any effect would be sentiment-driven rather than fundamental.

Evidence & confidence

The filing is a primary insider transaction disclosure with a stated pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.

Market effects

Limited read-through to the AI software/enterprise AI sector; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, the sale size can still be interpreted by some traders as a near-term overhang on sentiment.

Key entities

  • C3.ai, Inc.

    Subject of the Form 4 insider transaction disclosed in the article.

  • Lath Hitesh

    Chief Financial Officer who sold 48,619 shares at $8.77 under a 10b5-1 plan.

Related articles

$AIMed

Trump Family Pockets Half A Billion As Trump-Backed Crypto Firm Moves To Sell Only Revenue-Generating Business

The Wall Street Journal reports Nasdaq-listed AI Financial (formerly Alt5 Sigma) is in talks to sell its only revenue-generating payments subsidiary to Tokyo-based Perpetuals.com for up to $15 million. The unit generated about $25 million revenue in 2024. AI Financial’s losses followed World Liberty’s August 2025 WLFI token purchase and WLFI’s ~70% decline, with AI Financial reporting a $271 million quarterly loss.

$AIMedAI 9/10

C3.ai Q4 2026 Earnings Call Transcript - C3.ai (NYSE:AI)

C3.ai held its Q4 earnings call, reporting total revenue of $51.6 million, with subscription revenue 94% of the total. The company said it cut headcount about 35% and expects ~$135 million in annual operating cost savings. CEO Tom Siebel cited poor sales execution and plans to expand its target accounts. FY2027 guidance calls for $210–$240 million revenue and non-GAAP operating loss of $128–$160 million.

$AIHighAI 9/10

Live: Will C3.ai Beat Q4 Earnings After the Bell Tonight?

C3.ai (AI) reports Q4 fiscal 2026 results after the close. The company is focused on revenue within guidance ($48.0M–$52.0M), improving GAAP gross margin from 17% (down from 59% a year earlier), and expanding federal bookings, which rose 134% YoY to 55% of total bookings. Wall Street has 6 sell and 7 hold ratings; average target is $8.82 vs. $10.51.

$AIMedAI 8/10

Wall Street Has a Consensus on This AI Stock. The Consensus Is Dead Wrong.

The article argues that Wall Street’s consensus on C3.ai (AI) is inconsistent and may not reflect deteriorating fundamentals. It cites a hold consensus from 12 analysts with an average price target near $17 versus a stock price around $9.50. For fiscal Q1 2026 ended July 31, C3.ai reported about $50M revenue, missed guidance, posted a $0.40 loss per share vs $0.30 estimate, and guided continued pressure.

$AIMedAI 9/10

Thomas Siebel Is Back as C3.ai CEO. Will This Help the Stock Rebound?

C3.ai shares are down 59% over 12 months as the company’s sales have declined, despite having 100+ enterprise AI turnkey solutions. After CEO/founder Thomas Siebel stepped down in 2024 for health reasons and Stephen Ehikian took over Sept. 1, 2025, C3.ai reported preliminary Q4 revenue of $51.6M vs. $108.7M a year earlier. The company says Siebel returned as CEO May 8.